BofA upgraded Beam Therapeutics (BEAM) to Buy from Neutral with a $42 price target Light Up your Portfolio with Spark:Easily identify stocks' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback